Jupiter Bioscience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08	Mar ' 07

Sources of funds

Owner's fund

Equity share capital

62.43

16.13

16.13

18.13

9.86

Share application money

44.95

44.95

29.20

9.34

22.13

Preference share capital

-

-

-

-

-

Reserves & surplus

691.35

307.90

280.86

274.30

134.45

Loan funds

Secured loans

358.89

361.70

254.29

161.92

99.55

Unsecured loans

38.00

32.36

22.71

28.44

65.66

Total

1,195.62

763.05

603.19

492.13

331.65

Uses of funds

Fixed assets

Gross block

539.42

445.58

347.28

256.87

155.92

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

170.77

126.29

91.08

64.85

47.51

Net block

368.65

319.29

256.20

192.02

108.41

Capital work-in-progress

173.50

138.86

94.41

79.89

55.23

Investments

503.04

177.84

147.88

126.19

85.58

Net current assets

Current assets, loans & advances

202.84

138.46

115.08

99.58

75.53

Less : current liabilities & provisions

52.41

26.30

28.90

27.69

18.88

Total net current assets

150.42

112.16

86.18

71.89

56.66

Miscellaneous expenses not written

-

14.90

18.52

22.15

25.77

Total

1,195.62

763.05

603.19

492.13

331.65

Notes:

Book value of unquoted investments

502.04

176.84

146.88

125.19

84.58

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

7.03

-

-

Number of equity sharesoutstanding (Lacs)

624.33

161.33

161.33

181.33

98.62